Literature DB >> 16500585

Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure.

Tomohiro Dohke1, Atsuyuki Wada, Takahiro Isono, Masanori Fujii, Takashi Yamamoto, Takayoshi Tsutamoto, Minoru Horie.   

Abstract

BACKGROUND: Because congestive heart failure (CHF) is a complex syndrome with many different underlying mechanisms of worsening of heart function, it is important to recognize the global alternations in protein expression associated with the processes of CHF. METHODS AND
RESULTS: The purpose of our study was to use a proteomic approach to investigate global alternations in protein expression in tachycardia induced CHF dogs. We compared the 2-dimensional electrophoresis protein patterns of left ventricular samples from the normal with those from failing myocardium. Differentially expressed cardiac proteins showed approximately 500 cardiac protein spots. A total of 20 spots (14 increased, 6 decreased) was altered in CHF, whereas the more distinguishably increased spots in CHF were identified by using mass spectrometry as alpha B crystallin, heat shock protein (HSP) 27, and HSP20, which maintain both the morphologic and functional integrity of the cardiomyocytes and increase tolerance against various types of stress. Because phosphorylation is one of the most important posttranslational modifications, we evaluated whether or not the overexpressed small HSPs were phosphorylated in CHF. Phosphoprotein staining and Western blotting demonstrated that the phosphorylation of alpha B crystallin at serine (Ser)-59 site and of HSP27 at both Ser-78 and Ser-82 sites increased in CHF.
CONCLUSION: Proteomics studies can provide new insights into molecular mechanisms in CHF and phosphorylated small HSPs may be involved in preventing cardiac dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500585     DOI: 10.1016/j.cardfail.2005.07.006

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  29 in total

Review 1.  Small heat shock protein 20 (HspB6) in cardiac hypertrophy and failure.

Authors:  Guo-Chang Fan; Evangelia G Kranias
Journal:  J Mol Cell Cardiol       Date:  2010-09-30       Impact factor: 5.000

2.  Small heat shock protein 20 interacts with protein phosphatase-1 and enhances sarcoplasmic reticulum calcium cycling.

Authors:  Jiang Qian; Elizabeth Vafiadaki; Stela M Florea; Vivek P Singh; Weizhong Song; Chi Kung Lam; Yigang Wang; Qunying Yuan; Tracy J Pritchard; Wenfeng Cai; Kobra Haghighi; Patricia Rodriguez; Hong-Sheng Wang; Despina Sanoudou; Guo-Chang Fan; Evangelia G Kranias
Journal:  Circ Res       Date:  2011-04-14       Impact factor: 17.367

Review 3.  The small heat shock protein, HSPB6, in muscle function and disease.

Authors:  Catherine M Dreiza; Padmini Komalavilas; Elizabeth J Furnish; Charles R Flynn; Michael R Sheller; Christopher C Smoke; Luciana B Lopes; Colleen M Brophy
Journal:  Cell Stress Chaperones       Date:  2009-07-01       Impact factor: 3.667

4.  Characterization of hsp27 kinases activated by elevated aortic pressure in heart.

Authors:  Benoit Boivin; Maya Khairallah; Raymond Cartier; Bruce G Allen
Journal:  Mol Cell Biochem       Date:  2012-08-10       Impact factor: 3.396

5.  Inducible expression of heat shock protein 20 protects airway epithelial cells against oxidative injury involving the Nrf2-NQO-1 pathway.

Authors:  Aihua Bao; Aying Ma; Hui Zhang; Lihua Qiao; Suqin Ben; Xin Zhou; Min Zhang
Journal:  Cell Biosci       Date:  2020-10-19       Impact factor: 7.133

6.  A change of heart: oxidative stress in governing muscle function?

Authors:  Martin Breitkreuz; Nazha Hamdani
Journal:  Biophys Rev       Date:  2015-06-27

Review 7.  The BAG3-dependent and -independent roles of cardiac small heat shock proteins.

Authors:  Xi Fang; Julius Bogomolovas; Christa Trexler; Ju Chen
Journal:  JCI Insight       Date:  2019-02-21

8.  Heat shock protein 25-enriched plasma transfusion preconditions the heart against doxorubicin-induced dilated cardiomyopathy in mice.

Authors:  Karthikeyan Krishnamurthy; Ragu Kanagasabai; Lawrence J Druhan; Govindasamy Ilangovan
Journal:  J Pharmacol Exp Ther       Date:  2012-03-21       Impact factor: 4.030

9.  Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice.

Authors:  Kaushik Vedam; Yoshinori Nishijima; Lawrence J Druhan; Mahmood Khan; Nicanor I Moldovan; Jay L Zweier; Govindasamy Ilangovan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

10.  MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20.

Authors:  Jinghai Wu; Xiao-Ping Ren; Xiaohong Wang; Maureen A Sartor; Keith Jones; Jiang Qian; Persoulla Nicolaou; Tracy J Pritchard; Guo-Chang Fan
Journal:  Circulation       Date:  2009-04-20       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.